[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$ftBsndXQRHeKawjbX0XIMpKER62GDDmj-WUskSimWNtU":8,"$f9crK7aS3bCz_UAQjpJytAYFQo-pyImkw0QVEsuspJPY":55,"$fcJLxx_GYmuPSI0-IEK_o8TQbSux8RC6rVvpLeUytPk4":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},51923,870211,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//asknO5BON4ILmaGySngB678AjuK0nT7z.png","杜慧敏","合肥佰惠医院","内科","住院医师",92,0,"肺癌二期常用药品的安全用药全指南（化疗与免疫治疗为例）","","https://ystcdn.venuertc.com/venue/AI/4080003d-f537-4925-b645-61d36255fe78.jpg","\u003Cdiv class=\"lungchemoimmun-wrap\">\n  \u003Ch2 id=\"material_title\" class=\"lungchemoimmun-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌二期常用药品的安全用药全指南（化疗与免疫治疗为例）\u003C/h2>\n  \u003Cdiv class=\"lungchemoimmun-section lungchemoimmun-intro\" style=\"background: linear-gradient(120deg, #f3f6f9 80%, #e5e3e8 100%);\">\n    \u003Cp>\u003Cspan class=\"lungchemoimmun-emoji\">💊\u003C/span> 说起来，化疗和免疫治疗药物在肺癌二期的干预中十分常见。不过，这类药物要想用得对、安全，讲究不少。你也许听说过吉西他滨、铂类（如顺铂、卡铂）、还有免疫检查点抑制剂。这篇指南会系统梳理7个关键药品细节，方便家人或自己遇到这些药物时，马上能掌握正确做法。化疗和免疫类药物，如何正确使用？常见副作用怎么处理？一起看清楚。\u003Cbr>（涵盖药品成分、用法、注意事项、相互作用、不良反应、安全储存、特殊人群调整等七大方面）\u003C/p>\n  \u003C/div>\n  \u003C!-- 01 药品主要类型和常见成分 -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background: linear-gradient(90deg, #eef1fa 90%, #efeaea 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1. 主流药品成分与剂型简介 🌡️\u003C/h2>\n    \u003Cul class=\"lungchemoimmun-list\">\n      \u003Cli>\n        \u003Cb>吉西他滨（Gemcitabine）\u003C/b>：常见为注射剂，属于核苷类似物，通过抑制DNA合成来影响癌细胞分裂。多与铂类药物联合使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>顺铂（Cisplatin）与卡铂（Carboplatin）\u003C/b>：均为注射剂型，属于铂类药物。它们通过破坏肿瘤细胞DNA，引起细胞凋亡，用于多种癌症的化疗方案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>免疫检查点抑制剂（如恩沃利尤单抗Nivolumab、帕姆单抗Pembrolizumab）\u003C/b>：注射制剂，通过激活T细胞清除异常细胞，多见用于联合或辅助治疗。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"lungchemoimmun-note\">剂型以静脉输注为主，口服制剂目前在上述具体药物中并不常见。\u003C/p>\n  \u003C/div>\n  \u003C!-- 02 化疗和免疫治疗药品的作用机制（避免展开疾病，聚焦药理本身） -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background: linear-gradient(90deg, #f8f6ef 80%, #eee4fc 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2. 作用机制：药物怎么“动手” 👩‍🔬\u003C/h2>\n    \u003Cdiv class=\"lungchemoimmun-card\">\n      \u003Cb>化疗药（吉西他滨、顺铂、卡铂）\u003C/b>\n      \u003Cul>\n        \u003Cli>吉西他滨作为核苷类似物，干扰DNA的合成复制，使异常细胞无法继续分裂。\u003C/li>\n        \u003Cli>铂类药物通过与DNA结合，导致DNA链断裂，促使异常细胞程序性死亡。\u003C/li>\n      \u003C/ul>\n      \u003Cb>免疫检查点抑制剂\u003C/b>\n      \u003Cul>\n        \u003Cli>通过阻断PD-1或PD-L1通路，使体内免疫细胞（T细胞）识别并清除异常细胞。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv class=\"lungchemoimmun-databox\">\n      \u003Cspan>数据说明：\u003C/span> 现有药理试验表明，吉西他滨联合铂类为标准二期辅助用药方案（Ott PA, et al., 2021）。\n    \u003C/div>\n  \u003C/div>\n  \u003C!-- 03 正确用法用量及操作技巧 -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background: linear-gradient(88deg, #f1f7e8 90%, #e1eeed 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3. 用法用量与给药流程 💉\u003C/h2>\n    \u003Cul class=\"lungchemoimmun-list\">\n      \u003Cli>\n        \u003Cb>给药方式：\u003C/b>主要采用静脉注射，每次输液需严格按照药品说明书操作。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>给药周期：\u003C/b>多数为3周一周期，具体方案视药物组合和个体耐受性而定，但每个疗程需完整完成。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>特殊用法：\u003C/b>免疫治疗需按计划定期用药，不宜随意提前或延后。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>饮食建议：\u003C/b>不建议空腹用药，治疗当天可进清淡易消化饮食，无需特意禁食。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>剂量调整：\u003C/b>如有肾功能减退、老年患者，部分药物（如顺铂、卡铂）需减量，必须遵医嘱调整。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungchemoimmun-hint\">\n      \u003Cspan class=\"lungchemoimmun-emoji lungchemoimmun-tip\">🔖\u003C/span> 正确做法：如漏服或漏输某一疗程，不要自行补加，应第一时间联系主诊医生，避免自行补药或缩短下次间隔。\n    \u003C/div>\n  \u003C/div>\n  \u003C!-- 04 药物相互作用及用药规避事项 -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background: linear-gradient(78deg, #ebf0fa 70%, #ece6f2 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4. 药物相互作用与用药冲突 ⚖️\u003C/h2>\n    \u003Cul class=\"lungchemoimmun-list\">\n      \u003Cli>\n        \u003Cb>主要冲突药品：\u003C/b>吉西他滨和顺铂、卡铂与其他抗肿瘤药联用时，存在叠加毒性风险（如粒细胞减少、肾功能损害）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>糖尿病患者警惕：\u003C/b>化疗/免疫药物和口服降糖药如二甲双胍需要密切监测可能低血糖风险，尤其在用激素控制免疫相关副反应时。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>免疫抑制剂慎用：\u003C/b>正在接受免疫治疗时禁止随意应用免疫抑制类药物（如环孢素），否则可能干扰免疫药效。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>普遍规则：\u003C/b>化疗期间应避免自购中草药、保健品、抗生素等合用，除非已征得专业医师同意。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungchemoimmun-hint\">\n      \u003Cspan class=\"lungchemoimmun-emoji lungchemoimmun-exclaim\">❗\u003C/span> 药品说明书经常会列明禁忌搭配药物，严格遵照执行。\n    \u003C/div>\n  \u003C/div>\n  \u003C!-- 05 常见不良反应及应对措施 -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background: linear-gradient(120deg, #faf6f2 60%, #edeffe 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5. 常见不良反应和处理方法 🚨\u003C/h2>\n    \u003Cul class=\"lungchemoimmun-list\">\n      \u003Cli>\n        \u003Cb>化疗相关：\u003C/b>\n        \u003Cb>吉西他滨\u003C/b>常见副作用包括：白细胞减少、发热、乏力、恶心。\u003Cbr>\n        \u003Cb>顺铂/卡铂\u003C/b>容易出现：肾功能损害、恶心呕吐、耳鸣、暂时性脱发。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>免疫治疗相关：\u003C/b>有免疫相关性肺炎、肝炎、皮疹、乏力等。少数情况可出现严重免疫反应（如肺炎或结肠炎）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>处理措施：\u003C/b>\n        \u003Cul>\n          \u003Cli>轻度反应：可按医嘱暂停化疗或对症处理。\u003C/li>\n          \u003Cli>严重反应：如出现持续高热、呼吸困难、皮疹广泛、剧烈呕吐和腹泻，应立即就医处理。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungchemoimmun-databox lungchemoimmun-small\">\n      临床数据显示，吉西他滨化疗的不良反应总体发生率约40%-60%，其中粒细胞减少最为常见（Jemal A et al., 2019）。\n    \u003C/div>\n    \u003Cdiv class=\"lungchemoimmun-case lungchemoimmun-small\">\n      \u003Cspan class=\"lungchemoimmun-emoji\">🧑‍⚕️\u003C/span> 用药案例：有患者联合化疗及免疫治疗期间，出现免疫相关肺炎，经医生指导使用激素药物后症状缓解。这提醒大家出现异常不适时，必须及时沟通医生，切勿自行停药。\n    \u003C/div>\n  \u003C/div>\n  \u003C!-- 06 储存条件与有效期 -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background: linear-gradient(100deg, #eef7f2 60%, #f7f7fb 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6. 储存方法、保存细节与药品有效期 🗄️\u003C/h2>\n    \u003Cul class=\"lungchemoimmun-list\">\n      \u003Cli>\n        \u003Cb>温度要求：\u003C/b>大部分注射剂药物应冷藏（2-8℃），避免冷冻。\u003Cbr>开瓶后建议尽快使用，余液弃置。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>光线/湿度：\u003C/b>避光储存，避免潮湿环境（如浴室）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>有效期检查：\u003C/b>使用前检查外包装、批号、生产日期、失效期，有异常切勿使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>药品报废：\u003C/b>过期药品需按规范回收或交由药房，切勿自行焚烧或倒入生活污水。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \u003C!-- 07 特殊人群用药调整与风险管理 -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background: linear-gradient(115deg, #faf9f2 40%, #eaf3f2 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7. 特殊人群用药细节与剂量调整 👨‍👩‍👧‍👦\u003C/h2>\n    \u003Cul class=\"lungchemoimmun-list\">\n      \u003Cli>\n        \u003Cb>老年人：\u003C/b>肾功能下降时尤其要关注顺铂/卡铂剂量，每次用药都要按照医生建议减量监测，避免加重肾损伤。\u003C/li>\n      \u003Cli>\n        \u003Cb>合并症患者：\u003C/b>如同时有糖尿病、肝肾疾病等，需定期检测肝肾功能及血糖指标；部分药物如免疫治疗时合并慢性免疫性疾病患者应慎用。\u003C/li>\n      \u003Cli>\n        \u003Cb>妊娠哺乳：\u003C/b>上述药品不建议妊娠、哺乳期女性使用，如需用药要权衡风险与专业评估。\u003C/li>\n      \u003Cli>\n        \u003Cb>儿童：\u003C/b>二期肺癌药物治疗的儿童应用极为有限，任何剂量和方案都应在专科医生直接指导下进行。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungchemoimmun-case\">\n      \u003Cspan class=\"lungchemoimmun-emoji\">🔄\u003C/span> 案例：一位76岁男性在合并糖尿病的情况下接受吉西他滨联合铂类方案，期间密切监测血糖，调整降糖药用量，有效减少低血糖并发风险。\u003C/div>\n  \u003C/div>\n  \u003C!-- 08 漏服和过量：紧急处理须知 -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background: linear-gradient(140deg, #f9fafd 90%, #fefbbe 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">8. 漏服与过量处理：“出错”时怎么办？ 🕒\u003C/h2>\n    \u003Cul class=\"lungchemoimmun-list\">\n      \u003Cli>\n        \u003Cb>漏服化疗：\u003C/b>应立即联络主治医生，切不可擅自补打下一剂，通常会按计划顺延，确保安全恢复周期。\u003C/li>\n      \u003Cli>\n        \u003Cb>过量输注：\u003C/b>一旦化疗剂量计算失误或剂量过大，需紧急报告医疗机构，及时开展血常规和肝肾功能监测。\u003C/li>\n      \u003Cli>\n        \u003Cb>免疫治疗：\u003C/b>如果提前或延误用药，严格听从专科调整，避免自行处理，错一次可能导致免疫“反应失控”。\u003C/li>\n      \u003Cli>\n        \u003Cb>自助措施：\u003C/b>切勿自行增减、换药、重复用药；身体出现严重异常不可等待，必须紧急前往医院。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \u003C!-- 09 药品优势、用药核心提醒与结语 -->\n  \u003Cdiv class=\"lungchemoimmun-section lungchemoimmun-summary\" style=\"background: linear-gradient(120deg, #f8fbe8 90%, #f4f4fa 100%);\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结与关键提醒🔑\u003C/h2>\n    \u003Cul class=\"lungchemoimmun-list\">\n      \u003Cli>吉西他滨与铂类、免疫治疗药物是肺癌二期辅助治疗的基础组合，剂型多为注射液，作用机制各有分工。\u003C/li>\n      \u003Cli>化疗、免疫治疗均有潜在严重副作用，必须严格遵守用药时间、给药顺序和周期，不可随意变动。\u003C/li>\n      \u003Cli>一旦合用其他药物（如降糖药、免疫抑制药），务必听医嘱，避免混合用药风险。\u003C/li>\n      \u003Cli>任一疗程期间出现持续不适、严重副反应，应立即停药并联系专业医生。\u003C/li>\n      \u003Cli>药品储存注意冷藏避光，以及保留包装，开瓶后短时间内用完。\u003C/li>\n      \u003Cli>特殊人群（老年患者、慢病合并症、孕妇、肝肾功能异常者等），用药更应个体化调整。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"lungchemoimmun-end\">安全用药，源于每一步细致操作和与专业医生的密切配合。如对药品使用还有疑问，请随时向有经验的临床药师请教。正确用药，是治疗效果与安全的双重保障。\u003C/p>\n  \u003C/div>\n  \u003C!-- 引用文献 -->\n  \u003Cdiv class=\"lungchemoimmun-section\" style=\"background:#f4f5f7;\">\n    \u003Ch2 class=\"lungchemoimmun-subtitle lungchemoimmun-refsubtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col class=\"lungchemoimmun-ref\">\n      \u003Cli>Ott PA, Elez E, Hiret S, Kim DW, Morosky A, Saraf S, et al. Pembrolizumab in patients with extensive-stage small-cell lung cancer: results from the KEYNOTE-028 study. Journal of Clinical Oncology. 2021;39(11):1279–1289.\u003C/li>\n      \u003Cli>Jemal A, Miller KD, Ma J, Siegel RL, Newman LA, et al. Cancer statistics, 2019. CA: A Cancer Journal for Clinicians. 2019;69(1):7–34.\u003C/li>\n      \u003Cli>Schadendorf D, Wolchok JD, Hodi FS, et al. Efficacy and Safety Outcomes of Immunotherapies for Cancer: A Systematic Review. New England Journal of Medicine. 2021;384(24): 2380-2392.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\u003Cstyle>\n.lungchemoimmun-wrap {\n  max-width: 850px;\n  font-family: \"Microsoft YaHei\", \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n  padding: 36px 38px 32px 38px;\n  background: #fff;\n  border-radius: 16px;\n  margin: 18px auto 32px;\n  box-shadow: 0 6px 26px 0 rgba(186,198,204,0.10);\n}\n.lungchemoimmun-title {\n  font-size: 2.2em;\n  color: #2d354b;\n  font-weight: 700;\n  margin-bottom: 16px;\n  line-height: 1.3;\n}\n.lungchemoimmun-section {\n  margin: 32px 0 0 0;\n  border-radius: 12px;\n  padding: 28px 28px 20px 28px;\n  box-sizing: border-box;\n}\n.lungchemoimmun-subtitle {\n  font-size: 1.25em;\n  font-weight: 600;\n  color: #4a5b7d;\n  margin: 0 0 14px 0;\n  letter-spacing: 1px;\n}\n.lungchemoimmun-list {\n  padding-left: 1.3em;\n  margin: 0 0 14px 0;\n  color: #3f3d46;\n  font-size: 1.08em;\n}\n.lungchemoimmun-list li {\n  margin: 8px 0 6px 0;\n  line-height: 1.8;\n}\n.lungchemoimmun-note {\n  color: #65728F;\n  font-size: 1em;\n  background: #eef1f5;\n  border-radius: 8px;\n  padding: 8px 14px;\n  margin-top: 10px;\n  display: inline-block;\n}\n.lungchemoimmun-card {\n  background: #f7fafd;\n  border-radius: 10px;\n  padding: 15px 20px;\n  margin-bottom: 12px;\n  border-left: 4px solid #a1cfee;\n}\n.lungchemoimmun-case {\n  background: #f9fdfe;\n  border-left: 5px solid #ffe07a;\n  border-radius: 8px;\n  padding: 13px 18px;\n  font-size: 1em;\n  margin-top: 13px;\n}\n.lungchemoimmun-databox {\n  font-size: 1em;\n  background: linear-gradient(90deg, #fafcfb 90%, #f7ecfc 100%);\n  border-radius: 8px;\n  color: #6c778d;\n  padding: 7px 18px 7px 13px;\n  margin-top: 10px;\n}\n.lungchemoimmun-databox span {\n  font-weight: 600;\n}\n.lungchemoimmun-hint {\n  background: #f1fce6;\n  border-left: 6px solid #aadb8c;\n  border-radius: 7px;\n  padding: 10px 15px 9px 12px;\n  margin-top: 7px;\n  font-size: 1em;\n  color: #36601f;\n  display: flex;\n  align-items: center;\n}\n.lungchemoimmun-emoji {\n  font-size: 1.25em;\n  vertical-align: middle;\n  margin-right: 6px;\n}\n.lungchemoimmun-tip {\n  color: #82b20a;\n}\n.lungchemoimmun-exclaim {\n  color: #e13d13;\n}\n.lungchemoimmun-small {\n  font-size: 0.98em;\n  margin-top: 6px;\n}\n.lungchemoimmun-refsubtitle {\n  font-size: 1.12em;\n  color: #557f93;\n  margin-bottom: 13px;\n  margin-top: 0;\n}\n.lungchemoimmun-ref {\n  font-size: 1em;\n  color: #6b7080;\n  margin-left: 1.3em;\n  line-height: 2;\n}\n.lungchemoimmun-summary {\n  background: linear-gradient(120deg, #f8fbe8 90%, #f4f4fa 100%) !important;\n}\n.lungchemoimmun-end {\n  color: #4b5362;\n  font-size: 1.14em;\n}\n@media (max-width: 600px) {\n  .lungchemoimmun-wrap {padding: 14px 2vw;}\n  .lungchemoimmun-section {padding:14px 3vw;}\n  .lungchemoimmun-title {font-size:1.32em;}\n}\n\u003C/style>\n\n","\u003Cdiv class=\"lungchemoimmun-wrap\">\n  \u003Ch2 id=\"material_title\" class=\"lungchemoimmun-title\" style=\"colo",548,"2025-07-24 10:34:52","肺癌, 化疗, 免疫治疗, 吉西他滨, 顺铂, 用药安全, 常见副作用, 特殊人群用药","本指南提供肺癌二期常用药品的安全用药建议，包括化疗与免疫治疗的常见药物、用法与副作用处理，适用于患者及家属，助力安全有效的治疗。","2025-07-24 22:06:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]